Zevra Therapeutics, Inc.ZVRANASDAQ
LOADING
|||
EV to Sales: Premium Valuation
Trending higher, above historical average.
Left:
||||
Enterprise value to sales ratio
Latest
17.46
↑ 205% above average
Average (9y)
5.73
Historical baseline
Range
High:17.46
Low:0.00
Volatility
304.8%
High variability
| Period | Value | Change |
|---|---|---|
| 2024 | 17.46 | +105.8% |
| 2023 | 8.48 | -22.8% |
| 2022 | 10.98 | +111.9% |
| 2021 | 5.18 | -37.9% |
| 2020 | 8.35 | +22.4% |
| 2019 | 6.82 | - |
| 2018 | 0.00 | - |
| 2017 | 0.00 | - |
| 2016 | 0.00 | - |
| 2015 | 0.00 | - |